Preliminary study on the improvement of identifying effect of Tc-99 m labeled C595 monoclonal antibody in MUC1 imaging of ovarian cancer-Reference-Cited by-同舟云学术

Preliminary study on the improvement of identifying effect of Tc-99 m labeled C595 monoclonal antibody in MUC1 imaging of ovarian cancer

Published:2022-08-23 Issue:10 Volume:331 Page:4189-4195
ISSN:0236-5731
Container-title:Journal of Radioanalytical and Nuclear Chemistry
language:en
Short-container-title:J Radioanal Nucl Chem

Author:

Zhang Yan,Feng Yuzhen,Zhang Mei,Kong Deliang,Xiong Liyan,Yang Qinqin

Funder

Changhai Hospital of Shanghai

Science and Technology Innovation Plan Of Shanghai Science and Technology Commission

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Spectroscopy,Pollution,Radiology, Nuclear Medicine and imaging,Nuclear Energy and Engineering,Analytical Chemistry

Link

https://link.springer.com/content/pdf/10.1007/s10967-022-08478-9.pdf

Reference18 articles.

1. Taylor-Papadimitriou J, Burchell J, Miles DW, Dalziel M (1999) MUC1 and cancer. Biochim Biophys Acta 1455:301–313. https://doi.org/10.1016/s0925-4439(99)00055-1

2. Singh R, Bandyopadhyay D (2007) MUC1: a target molecule for cancer therapy. Cancer Biol Ther 6:481–486. https://doi.org/10.4161/cbt.6.4.4201

3. Bernier AJ, Zhang J, Lillehoj E et al (2011) Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasion. Mol Cancer 10:93. https://doi.org/10.1186/1476-4598-10-93

4. Deng J, Wang L, Chen H et al (2013) The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression. Cancer Metastasis Rev 32:535–551. https://doi.org/10.1007/s10555-013-9423-y

5. Nath S, Mukherjee P (2014) MUC1: a multifaceted oncoprotein with a key role in cancer progression. Trends Mol Med 20:332–342. https://doi.org/10.1016/j.molmed.2014.02.007